3.1(top 20%)
impact factor
10.4K(top 2%)
papers
392.6K(top 1%)
citations
188(top 2%)
h-index
3.2(top 20%)
impact factor
11.5K
all documents
411.6K
doc citations
266(top 2%)
g-index

Top Articles

#TitleJournalYearCitations
1An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patientsBreast Cancer Research and Treatment20102,480
2The Nottingham prognostic index in primary breast cancerBreast Cancer Research and Treatment1992913
3Effect of obesity on survival of women with breast cancer: systematic review and meta-analysisBreast Cancer Research and Treatment2010785
4Epidemiology of basal-like breast cancerBreast Cancer Research and Treatment2008747
5A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analysesBreast Cancer Research and Treatment2008732
6Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancerBreast Cancer Research and Treatment2011687
7miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patientsBreast Cancer Research and Treatment2016678
8Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An UpdateBreast Cancer Research and Treatment2004671
9Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neuBreast Cancer Research and Treatment1992670
10REporting recommendations for tumor MARKer prognostic studies (REMARK)Breast Cancer Research and Treatment2006666
11Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumorsBreast Cancer Research and Treatment1995642
12Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE TrialBreast Cancer Research and Treatment2001629
13Differentiation of the mammary gland and susceptibility to carcinogenesisBreast Cancer Research and Treatment1982582
14Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor studyBreast Cancer Research and Treatment2018564
15Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort studyBreast Cancer Research and Treatment2007532
16Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic reviewBreast Cancer Research and Treatment2012531
17Role of epidermal growth factor receptor in breast cancerBreast Cancer Research and Treatment2012529
18The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifenBreast Cancer Research and Treatment2007520
19Estrogen Receptor Breast Cancer Phenotypes in the Surveillance, Epidemiology, and End Results DatabaseBreast Cancer Research and Treatment2002479
20Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancerBreast Cancer Research and Treatment2008472
21Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancerBreast Cancer Research and Treatment2014472
22Pattern of metastatic spread in triple-negative breast cancerBreast Cancer Research and Treatment2009455
23Breast cancer survivors: Psychosocial concerns and quality of lifeBreast Cancer Research and Treatment1996450
24Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registryBreast Cancer Research and Treatment2013449
25Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancerBreast Cancer Research and Treatment2011433
26Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancerBreast Cancer Research and Treatment2006432
27Targeting breast stem cells with the cancer preventive compounds curcumin and piperineBreast Cancer Research and Treatment2010432
28Pharmacological Characterization of 4-hydroxy-N-desmethyl Tamoxifen, a Novel Active Metabolite of TamoxifenBreast Cancer Research and Treatment2004418
29Steroid hormone receptors in breast cancer managementBreast Cancer Research and Treatment1998401
30An overview of prognostic factors for long-term survivors of breast cancerBreast Cancer Research and Treatment2008396
31The role of vascular endothelial growth factor in pathological angiogenesisBreast Cancer Research and Treatment1995387
32Depression, quality of life and breast cancer: a review of the literatureBreast Cancer Research and Treatment2008375
33Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitroBreast Cancer Research and Treatment2007369
34Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancerBreast Cancer Research and Treatment2002366
35Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapyBreast Cancer Research and Treatment2007349
36Malignant MCF10CA1 Cell Lines Derived from Premalignant Human Breast Epithelial MCF10AT CellsBreast Cancer Research and Treatment2001346
37Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer researchBreast Cancer Research and Treatment1995344
38Significance of interleukin-6 (IL-6) in breast cancer (review)Breast Cancer Research and Treatment2007342
39Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancerBreast Cancer Research and Treatment1993338
40Pattern of distribution of cells positive for estrogen receptor α and progesterone receptor in relation to proliferating cells in the mammary glandBreast Cancer Research and Treatment1999338
41Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expressionBreast Cancer Research and Treatment1995337
42Physical activity and risk of breast cancer: a meta-analysis of prospective studiesBreast Cancer Research and Treatment2013335
43Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancerBreast Cancer Research and Treatment2017335
44Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotypeBreast Cancer Research and Treatment2012333
45Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GABreast Cancer Research and Treatment2009332
46Effects of anti-estrogens on bone in castrated and intact female ratsBreast Cancer Research and Treatment1987331
47MDA-MB-435 cells are derived from M14 Melanoma cells––a loss for breast cancer, but a boon for melanoma researchBreast Cancer Research and Treatment2007331
48HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trialBreast Cancer Research and Treatment2010330
49Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissueBreast Cancer Research and Treatment2001327
50An evaluation of the quality of life among long-term survivors of breast cancerBreast Cancer Research and Treatment1996320